Endo, Penwest sue Impax over painkiller's patent

07/29/2008 | American City Business Journals

Endo Pharmaceuticals Holdings and Penwest Pharmaceuticals filed a patent-infringement suit against Impax Laboratories over its application to make a generic version of the companies' painkiller, Opana ER. The dispute centers on an amendment of Impax's application to include 7.5 mg, 15 mg and 30 mg dosages of the drug.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX